Search research articles
Contact Us
Filters
Showing results (291-300 of 304) with videos related to
Page
of 31
Sort By:
British Journal of Clinical Pharmacology
|
April 9, 2020
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y<sub>12</sub> inhibitor
Yifan Zhang, Xiaoxue Zhu, Yan Zhan, et al.
Journal of Medicinal Chemistry
|
June 4, 2008
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies
Xiaoan Wen, Hongbin Sun, Jun Liu, et al.
Plos One
|
December 15, 2012
Outcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort study
Yida Hu, Xishun Huang, Dinglie Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 8, 2021
STING inhibitors target the cyclic dinucleotide binding pocket
Ze Hong, Jiahao Mei, Chenhui Li, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 19, 2022
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention
Xin Zhao, Sicong Ma, Yi Kang, et al.
Cell Metabolism
|
May 11, 2023
Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4
Hongbin Sun, Wei Lin, Yu Tang, et al.
European Journal of Medicinal Chemistry
|
March 29, 2011
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies
Zhongjie Liang, Liying Zhang, Lianchun Li, et al.
Immunity
|
December 7, 2024
Elevated IL-22 as a result of stress-induced gut leakage suppresses septal neuron activation to ameliorate anxiety-like behavior
Mengyu Xia, Junmei Lu, Jiabin Lan, et al.
Frontiers in Pharmacology
|
July 6, 2018
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
Xiaojiao Li, Cai Liu, Xiaoxue Zhu, et al.
Nature Communications
|
September 29, 2025
Molecular mechanisms of CBASS phospholipase effector CapV mediated membrane disruption
Jianping Kong, Wanqian Wu, Shiyue Ke, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 304) with videos related to
Sort By:
Page
of 31
British Journal of Clinical Pharmacology
|
April 9, 2020
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y<sub>12</sub> inhibitor
Yifan Zhang, Xiaoxue Zhu, Yan Zhan, et al.
Journal of Medicinal Chemistry
|
June 4, 2008
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies
Xiaoan Wen, Hongbin Sun, Jun Liu, et al.
Plos One
|
December 15, 2012
Outcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort study
Yida Hu, Xishun Huang, Dinglie Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 8, 2021
STING inhibitors target the cyclic dinucleotide binding pocket
Ze Hong, Jiahao Mei, Chenhui Li, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 19, 2022
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention
Xin Zhao, Sicong Ma, Yi Kang, et al.
Cell Metabolism
|
May 11, 2023
Sustained remission of type 2 diabetes in rodents by centrally administered fibroblast growth factor 4
Hongbin Sun, Wei Lin, Yu Tang, et al.
European Journal of Medicinal Chemistry
|
March 29, 2011
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies
Zhongjie Liang, Liying Zhang, Lianchun Li, et al.
Immunity
|
December 7, 2024
Elevated IL-22 as a result of stress-induced gut leakage suppresses septal neuron activation to ameliorate anxiety-like behavior
Mengyu Xia, Junmei Lu, Jiabin Lan, et al.
Frontiers in Pharmacology
|
July 6, 2018
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers
Xiaojiao Li, Cai Liu, Xiaoxue Zhu, et al.
Nature Communications
|
September 29, 2025
Molecular mechanisms of CBASS phospholipase effector CapV mediated membrane disruption
Jianping Kong, Wanqian Wu, Shiyue Ke, et al.
Page
of 31